Tower Research Capital LLC (Trc) Alkermes Plc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Alkermes Plc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 20,674 shares of ALKS stock, worth $741,989. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,674
Previous 4,190
393.41%
Holding current value
$741,989
Previous $117,000
407.69%
% of portfolio
0.01%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ALKS
# of Institutions
372Shares Held
175MCall Options Held
140KPut Options Held
143K-
Black Rock Inc. New York, NY29.1MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$664 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$440 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$316 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$271 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.9B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...